Bixalomer
Bixalomer is a phosphate binder. Bixalomer can improve hyperphosphatemia in chronic kidney disease (CKD) rat model. Bixalomer reduces plasma phosphorus level in CKD rat models through binding phosphate in small intestine and reduces phosphate absorption. Bixalomer can be studied in research on hyperphosphatemia[1].
Product Specifications
CAS Number
[851373-13-2]
UNSPSC
12352211
Target
Biochemical Assay Reagents
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
ClCC1OC1.NCCCN(CCCCN(CCCN)CCCN)CCCN.[n]
Molecular Formula
C19H45ClN6O
Molecular Weight
409.05
References & Citations
[1]Taniguchi, K., & Kakuta, H. (2015) . Bixalomer, a novel phosphate binder with a small swelling index, improves hyperphosphatemia in chronic kidney disease rat. European journal of pharmacology, 766, 129-134.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
